HARBOUR INVESTMENTS, INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$460
-15.9%
290.0%0.00%
Q2 2023$547
+392.8%
290.0%0.00%
Q1 2023$111
-56.1%
29
-43.1%
0.00%
Q4 2022$253510.0%0.00%
Q3 2022$0510.0%0.00%
Q2 2022$0510.0%0.00%
Q4 2021$051
-37.8%
0.00%
Q3 2021$082
+36.7%
0.00%
Q2 2021$0600.0%0.00%
Q1 2021$0600.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders